abstract mutations have been described in all of the four open reading frames of the hepatitis b virus (hbv), however, from a clinical perspective the surface escape mutant is the most troublesome. hepatitis b surface antigen (hbsag) variants may impair diagnosis, or allow the virus to escape vaccine-induced immunity or passive immunoglobulin therapy. hbv mutants with amino acid substitutions, ...

Hepatitis B virus (HBV) infection is contagious with transmissiobn vertically or horizontally by blood products and body secretions. Over 50% of Iranian carriers contracted the infection prenatally, making this the most likely route of transmission of HBV in Iran. To evaluate the resistance to adefovir (ADV) therapy in patients with chronic hepatitis B infection, a study was conducted on 70 pat...

xanthan gum is a microbial polysaccharide of great commercial importance as it has unusual rheological properties in solution and consequent range of applications. in this study, a series of mutants were isolated from xanthomonas campestris ptcc 1473 by ethyl methanesulfonate mutagenesis. the polysaccharide yield of one mutant, xc1473e2, was 30% better than that of the parent strain. it also sh...

background: gossypium arboreum is resistant to cotton leaf curl burewala virus and its cognate cotton leaf curl multan betasatellite (clcubuv and clcumb). however, the g. arboreum wax deficient mutant (gawm3) is susceptible to clcuv. therefore, epicuticular wax was characterized both quantitatively and qualitatively for its role as physical barrier against whitefly mediated viral transmission a...

A woman, born in 1958, developed hepatitis B virus fulminant hepatic failure and underwent ABO blood group incompatible orthotopic liver transplantation in 1989 and was retransplanted with an ABO identical graft in 1992 for chronic rejection. Since her first liver transplantation she had received regular anti-hepatitis B surface antigen immunoglobulins. Hepatitis B virus antigenemia became posi...

SEVERAL OPTIONS FOR THE TREATMENT OF HEPATITIS B HAVE BEEN LICENSED IN THE LAST YEARS: interferon, pegylated interferon, lamivudine, adefovir, entecavir, and telbivudine. In addition tenofovir has been licensed in the EU and is expected to be licensed in the USA in 2008. The antivirals can be divided into "lamivudine-like" and "adefovir-like", which clinically differ in their capacity to induce...